Published in Biochem Biophys Res Commun on July 31, 1992
Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany NY) (2009) 1.62
Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy. Mol Cancer Ther (2009) 1.34
Modulating the tumor microenvironment to increase radiation responsiveness. Cancer Biol Ther (2009) 1.18
The interactions of flavonoids within neuronal signalling pathways. Genes Nutr (2007) 1.11
Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising. Front Oncol (2014) 1.06
The impact of flavonoids on spatial memory in rodents: from behaviour to underlying hippocampal mechanisms. Genes Nutr (2009) 0.99
Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia (2009) 0.97
A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br J Pharmacol (2010) 0.96
Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle (2013) 0.95
Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology (1998) 0.89
Flavonoids: naturally occurring anti-inflammatory agents. Am J Pathol (1995) 0.89
Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1. Exp Parasitol (2010) 0.83
Inhibitors of phosphatidylinositol-3-kinase in cancer therapy. Mol Aspects Med (2010) 0.83
Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovasc Res (2012) 0.82
Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. ACS Chem Neurosci (2014) 0.82
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? World J Gastroenterol (2015) 0.82
Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose. J Neurochem (2016) 0.79
Pharmacological actions of nobiletin in the modulation of platelet function. Br J Pharmacol (2015) 0.77
Excited state proton transfer of natural flavonoids and their chromophores in duplex and tetraplex DNAs. J Phys Chem B (2014) 0.75
Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship. PLoS One (2016) 0.75
The Role of Phospholipase D in Regulated Exocytosis. J Biol Chem (2015) 0.75
Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues. Bioorg Med Chem (2006) 0.75
CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia. Oncotarget (2017) 0.75
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 14.36
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol (1994) 5.13
Skull x-ray examinations after head trauma. Recommendations by a multidisciplinary panel and validation study. N Engl J Med (1987) 4.07
Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation (1999) 3.35
Lay constructions of decision-making in cancer. Psychooncology (2002) 2.03
Induction of deoxyribonucleic acid synthesis in the liver of the intact animal. J Biol Chem (1972) 1.85
Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J (1996) 1.78
Oncologists' reactions to cancer patients' verbal cues. Psychooncology (2002) 1.61
Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem (1995) 1.57
The concept, design, and operation of a radiological health science education unit. Radiology (1971) 1.46
Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol (1995) 1.42
Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J Immunol (1995) 1.35
Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J Biol Chem (1995) 1.34
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun (2001) 1.33
Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem (1990) 1.30
Calmodulin activates phosphatidylinositol 3-kinase. J Biol Chem (1997) 1.25
Synthesis of deoxyribonucleic acid by isolated liver nuclei. J Biol Chem (1970) 1.24
Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem Biophys Res Commun (1994) 1.19
Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem (1996) 1.18
Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption. Am J Physiol (1999) 1.13
Salmonella typhi 205aTy, a strain with two attenuating auxotrophic characters, for use in laboratory teaching. Infect Immun (1987) 1.11
Phosphatidylinositol 3-kinase activation is required for insulin-stimulated sodium transport in A6 cells. Am J Physiol (1998) 1.08
Protein kinase C-alpha and -epsilon modulate connexin-43 phosphorylation in human heart. J Mol Cell Cardiol (2001) 1.07
LY-294002-inhibitable PI 3-kinase and regulation of baseline rates of Na(+) transport in A6 epithelia. Am J Physiol Cell Physiol (2000) 1.04
The utilization and efficacy of pelvimetry. Am J Roentgenol Radium Ther Nucl Med (1975) 1.02
Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. J Mol Cell Cardiol (2001) 1.00
Compartmental system analysis: state of the art. IEEE Trans Biomed Eng (1980) 1.00
Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases. J Cell Physiol (1997) 1.00
Effect of inhibitors of protein synthesis on DNA formation in liver. Biochim Biophys Acta (1970) 0.98
Stimulation of food intake in horses by diazepam and promazine. Pharmacol Biochem Behav (1976) 0.94
Ultrastructure of rat lungs following exposure to aerosols of dibenzoxazepine (CR). Br J Exp Pathol (1979) 0.94
The effect of some mycotoxins on the brine shrimp, Artemia salina. J Am Oil Chem Soc (1969) 0.93
Stress, depression, workplace and social supports and burnout in intellectual disability support staff. J Intellect Disabil Res (2011) 0.91
Dermabrasion--a novel concept in the surgical management of sulphur mustard injuries. Burns (2000) 0.91
Intercondylar T-shaped fractures of the humerus. Results in ten cases treated by early mobilisation. J Bone Joint Surg Br (1971) 0.91
An examination of the initial cancer consultation of medical and radiation oncologists using the Cancode interaction analysis system. Br J Cancer (2008) 0.91
Wortmannin and LY294002 inhibit the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes. Mol Cell Endocrinol (1995) 0.90
Possible involvement of phosphatidylinositol 3-kinase in regulated exocytosis: studies in chromaffin cells with inhibitor LY294002. J Neurochem (1998) 0.89
The histopathology of rat lung following short term exposures to mixed oxides of nitrogen (NOx). Br J Exp Pathol (1983) 0.88
Bacterial translocation can increase plasma corticosterone and brain catecholamine and indoleamine metabolism. Am J Physiol Regul Integr Comp Physiol (2000) 0.87
Gastroesophageal reflux and Nissen fundoplication following percutaneous endoscopic gastrostomy in children. J Pediatr Gastroenterol Nutr (1998) 0.87
An unusual dislocation of the hip. Br J Surg (1972) 0.87
Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty. J Am Coll Cardiol (1994) 0.87
Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol Pathol (1991) 0.86
Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci (1991) 0.86
Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol (1993) 0.86
Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. J Med Chem (1996) 0.86
Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells. Biochem Biophys Res Commun (2001) 0.86
Interviewing patients using interpreters in an oncology setting: initial evaluation of a communication skills module. Ann Oncol (2009) 0.85
Identifiable pharmacokinetic models: the role of extra inputs and measurements. J Pharmacokinet Biopharm (1980) 0.84
The repeated dose toxicity of a zinc oxide/hexachloroethane smoke. Arch Toxicol (1988) 0.84
Evidence for an essential arginine residue in the active site of Escherichia coli 2-keto-4-hydroxyglutarate aldolase. Modification with 1,2-cyclohexanedione. J Biol Chem (1985) 0.84
The biochemical and pathological changes produced by the intratracheal instillation of certain components of zinc-hexachloroethane smoke. Toxicology (1989) 0.84
Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain. Biochem J (1992) 0.83
Succinate dehydrogenase as an index of thermal injury to skin. Br J Exp Pathol (1973) 0.82
Insulin and insulin-like growth factor-I receptor mediated differentiation of 3T3-F442A cells into adipocytes: effect of PI 3-kinase inhibition. Biochem Biophys Res Commun (1998) 0.82
Variant cystic fibrosis in an elderly man. South Med J (1986) 0.82
Surgical care of the hand. Proc R Soc Med (1967) 0.82
Screening of chest roentgenograms by advanced roentgen technologists. Radiology (1970) 0.82
Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. J Biol Chem (1990) 0.82
Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. J Cell Biochem (1997) 0.82
Use of infliximab in pediatric patients with inflammatory bowel disease. Ann Pharmacother (2001) 0.82
Median nerve palsy after posterolateral elbow dislocation. J Bone Joint Surg Br (1994) 0.81
Isoindole. J Chem Soc Perkin 1 (1973) 0.81
Median nerve compression within the humeral head of pronator teres. J Hand Surg Br (1994) 0.80
Amino acid sequence of the pyruvate and the glyoxylate active-site lysine peptide of Escherichia coli 2-keto-4-hydroxyglutarate aldolase. J Biol Chem (1986) 0.80
Non-invasive quantification of skin injury resulting from exposure to sulphur mustard and Lewisite vapours. Burns (2000) 0.79
Coping with metastatic melanoma: the last year of life. Psychooncology (2000) 0.79
LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteins. J Lipid Res (1996) 0.79
Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain. J Biol Chem (1990) 0.79
Design and implementation of a particle concentration fluorescence method for the detection of HIV-1 protease inhibitors. Anal Biochem (1992) 0.79
Chlorpropamide inhibition of excision repair and postreplication repair of ultraviolet damage in Chinese hamster ovary cells. Mutat Res (1980) 0.79
First isolation of a calicivirus from the Steller sea lion (Eumetopias jubatus). J Wildl Dis (1987) 0.78
The development of Lewisite vapour induced lesions in the domestic, white pig. Int J Exp Pathol (1999) 0.78
Use of enzyme immunoassay for the rapid diagnosis of Chlamydia trachomatis endocervical infection in female adolescents. J Adolesc Health Care (1988) 0.78
Screening, diagnosis, and management of dyslipoproteinemia in children. Endocrinol Metab Clin North Am (1990) 0.77
Comparative reactivity of 1-carba-1-dethiacephalosporins with cephalosporins. J Med Chem (1990) 0.77
Effects of wortmannin analogs on bone in vitro and in vivo. J Pharmacol Exp Ther (1996) 0.77
Protein losing enteropathy as the initial manifestation of childhood systemic lupus erythematosus. J Rheumatol (1996) 0.77
Isolation of reptilian calicivirus Crotalus type 1 from feral pinnipeds. J Wildl Dis (1998) 0.77
Histochemistry of the burned dermis. Br J Exp Pathol (1972) 0.75
Ethics of clinical trials. N Engl J Med (2000) 0.75
Histochemistry of hypertrophic scars and keloids. Proc R Soc Med (1974) 0.75
Should there be an accredited ethics committee system for centralised review of multicentre clinical research? Med J Aust (1998) 0.75
Compound fractures of the tibia: the soft-tissue defect. Proc R Soc Med (1972) 0.75
Effects of experimental sarin intoxication on the morphology of the mouse diaphragm: a light and electron microscopical study. Int J Exp Pathol (1991) 0.75
Signaling pathways mediated by the beta(2)-adrenergic receptor in the fibroblast: a novel role for PI 3-kinase. J Mol Cell Cardiol (2001) 0.75
Compartmental modelling based on methionine tolerance test data: a case study. Med Biol Eng Comput (1979) 0.75
Gonad shielding in diagnostic radiology. Recommendation of the FDA and ACR. Postgrad Med (1979) 0.75
Inhalation toxicity of a smoke containing Solvent Yellow 33, Disperse Red 9 and Solvent Green 3 in laboratory animals. Hum Toxicol (1984) 0.75
Forensic dentistry--part I. J Indiana Dent Assoc (1982) 0.75
FDA and ACR recommend gonad shielding. Postgrad Med (1979) 0.75
Experimental determination of whole body average specific absorption rate (SAR) of mice exposed to 200-400 MHz CW. Bioelectromagnetics (1983) 0.75
American College of Radiology network and workstation. AJR Am J Roentgenol (1985) 0.75
Identifiability: its role in design of pharmacokinetic experiments. IEEE Trans Biomed Eng (1982) 0.75
Adequacy of measurements in compartmental modelling of metabolic systems. Med Biol Eng Comput (1979) 0.75
Comments on "some observations on the physical realizability of compartmental models with delays". IEEE Trans Biomed Eng (1979) 0.75
Forensic dentistry--part II. J Indiana Dent Assoc (1983) 0.75